Article
A Single Nucleotide Polymorphism rs1010816 Predicts Sorafenib Therapeutic Outcomes in Advanced Hepatocellular Carcinoma.
International journal of molecular sciences - 14 Jan 2023
Lin Chih-Lang, Liang Kung-Hao, Hu Ching-Chih, Chien Cheng-Hung, Chen Li-Wei, Chien Rong-Nan, Lin Yang-Hsiang, Yeh Chau-Ting
Abstract excerpt
Sorafenib is currently a targeted agent widely used in the treatment of advanced hepatocellular carcinoma (aHCC). However, to date there is still a lack of a reliable marker capable of predicting sorafenib therapeutic responses. Here, we conducted a genome-wide association study (GWAS) to identify candidate single-nucleotide polymorphism outcome predictors in aHCC patients. A total of 74 real-world...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
